Phase II study of oral miltefosine in patients with squamous cell head and neck cancer
- 31 December 1993
- journal article
- other
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (5) , 778-779
- https://doi.org/10.1016/s0959-8049(05)80369-7
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Phase I Study of Weekly Oral Miltefosine (Hexadecyl-Phosphocholine) in Cancer PatientsOncology Research and Treatment, 1991
- Hexadecylphosphocholine: a new and selective antitumor drugCancer Treatment Reviews, 1990
- Characterization of the antitumor activity of hexadecylphosphocholine (D 18506)European Journal of Cancer and Clinical Oncology, 1988